Alpine Immune Sciences, Inc.

ALPNNASDAQHealthcare

$64.97

+$0.01(+0.02%)

Market Cap$4.5B

P/E Ratio—

52W High$65.0

52W Low$8.33

Avg Volume2.5M

Open$64.98

Beta0.97

Overview

Alpine Immune Sciences, Inc. (ALPN) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · ALPN · as of Mar 20, 2024

Latest filing snapshot

142

+16+12.70%vs prior year

Alpine Immune Sciences, Inc. (ALPN) employee data is sourced from the annual SEC 10-K filing. As of 2023, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 10-K·Period end: 2023-12-31·Full-time · Global

Total Employees

142

Change (1Y)

+16

Growth % (1Y)

+12.70%

Revenue / Employee

$414.6K

Net Income / Employee

$-226.6K

Market Cap

$4.5B

ALPN Employee Count

2015 – 2023 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing Date	Period End	Employees	Change (1Y)	Growth (1Y)
2024-03-20	2023-12-31	142	+16	+12.70%
2023-03-23	2022-12-31	126	+41	+48.24%
2022-03-17	2021-12-31	85	+28	+49.12%
2021-03-18	2020-12-31	57	+4	+7.55%
2020-03-30	2019-12-31	53	+5	+10.42%
2019-03-18	2018-12-31	48	+10	+26.32%
2018-03-28	2017-12-31	38	+23	+153.33%
2017-02-13	2016-12-31	15	-14	-48.28%
2016-03-08	2015-12-31	29	—	—

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology

#SymbolCompanyEmployeesMkt Cap

MRTX

Mirati Therapeutics, Inc.

587$4.1B

ASPHF

Ascentage Pharma Group International

567$1.7B

GBT

Global Blood Therapeutics, Inc.

Alpine Immune Sciences, Inc.YOU

142$4.5B #6

CBAY

CymaBay Therapeutics, Inc.

101$3.7B

CCXI

Churchill Capital Corp XI

N/A$431M

Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · ALPN peer comparison

About ALPN employees

ALPN Employees · Headcount

Alpine Immune Sciences, Inc. (ALPN) employee data is sourced from the annual SEC 10-K filing. As of 2023, Alpine Immune Sciences, Inc. had 142 full-time employees globally. Full-time employees only. Global consolidated headcount.

Alpine Immune Sciences, Inc. employs 142 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $414,620, reflecting the company's operational efficiency.

Alpine Immune Sciences, Inc.'s workforce increased by 16 (12.70%) in 2023 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Alpine Immune Sciences, Inc.'s revenue per employee of $414,620 positions it among the notable performers in the Biotechnology sector for operational efficiency.

Revenue Financial statements Net income SEC filings Price history Forecast & ratings Ownership Earnings

Frequently Asked Questions

ALPN Employees · 5 questions

As of the latest SEC 10-K filing (2023), Alpine Immune Sciences, Inc. had 142 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Alpine Immune Sciences, Inc. employee counthow many employees does Alpine Immune Sciences, Inc. haveALPN total employees 2023

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2024-03-20